Next-generation phenotyping holds promise for antibiotic de-escalation

Definitive prenatal diagnosis currently relies on invasive techniques, but that may be changing

As drug test adulteration becomes more sophisticated, so do detection methods

The ability to diagnose drug resistance is improving treatment strategies and outcomes

RT-PCR is considered the gold standard, but certain situations may call for the use of RIDTs

More than half of commercially available glucometers do not meet recommended accuracy guidelines

Clinical utility and cost-effectiveness are key considerations

Genetically modified microbes designed to treat human disease have entered into preclinical and clinical development

Large data sets hold promise, but major challenges remain

A call to action for laboratories performing specific-IgE testing